We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
Enzymatically Synthesized Ginsenoside Exhibits Antiproliferative Activity in Various Cancer Cell Lines.
- Authors
Darsandhari, Sumangala; Shrestha, Biplav; Pandey, Ramesh Prasad; Lee, Sanghun; Jung, Hye Jin; Kim, Yeon Ju; Sohng, Jae Kyung
- Abstract
A glycoside derivative of compound K (CK) was synthesized by using a glycosyltransferase, and its biological activity was tested against various cancer-cell lines. A regiospecific, β-1,4-galactosyltransferase (LgtB) converted 100% of 0.5 mmol CK into a galactosylated product in 3 h. The structure of the synthesized derivative was revealed with high performance liquid chromatography, mass spectroscopy, as well as nuclear magnetic resonance analyses, and it was recognized as 20-O-β-D-lactopyranosyl-20(S)-protopanaxadiol (CKGal). Out of the four cancer-cell lines tested (gastric carcinoma (AGS), skin melanoma (B16F10), cervical carcinoma (HeLa), and brain carcinoma (U87MG)), CKGal showed the best cytotoxic ability against B16F10 and AGS when compared to other ginsenosides like compound K (20-O-β-D-glucopyranosyl-20(S)-protopanaxadiol), Rh2 (3-O-β-D-glucopyranosyl-20(S)-protopanaxadiol), and F12 (3-O-β-D-glucopyranosyl-12-O-β-D-glucopyranosyl-20(S)-protopanaxadiol). Thus, the synthesized derivative (CKGal) is a pharmacologically active ginsenoside.
- Subjects
GLYCOSIDES; CELL lines
- Publication
Applied Sciences (2076-3417), 2019, Vol 9, Issue 5, p893
- ISSN
2076-3417
- Publication type
Article
- DOI
10.3390/app9050893